Skip Navigation

A Phase II, Single-Arm Study of Bempegaldesleukin (Nktr-214) In Combination with Nivolumab In Cisplatin Ineligible, Locally Advanced or Metastatic Urothelial Cancer Patients

Brief Summary

Urologic / Genitourinary - Other

Study Type:

II Identifier:

Study #:

Start Date:
Jan 01, 0001

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT03785925

View Complete Trial Details & Eligibility at